Related Experiment Video
Updated: Jul 14, 2026
08:41
Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Lung disease in ataxia-telangiectasia.
L Bott1, Jp Lebreton, C Thumerelle
1Service de pédiatrie, CHU de Poitiers, Poitiers, France. lebreton.bott@cegetel.net
Acta Paediatrica (Oslo, Norway : 1992)
|May 26, 2007
Summary
Ataxia-telangiectasia (AT) lung disease often presents with recurrent infections in early childhood. Pulmonary status is a key prognostic factor, necessitating early monitoring and management to reduce AT morbidity.
Area of Science:
- Pulmonology
- Genetics
- Immunology
Background:
- Ataxia-telangiectasia (AT) is a severe multi-systemic genetic disorder caused by ATM gene mutations.
- Respiratory complications are a significant cause of morbidity and mortality in AT patients.
Purpose of the Study:
- To investigate the spectrum and clinical course of lung disease in patients with Ataxia-telangiectasia.
- To identify factors influencing pulmonary outcomes in AT.
Main Methods:
- Retrospective analysis of lung disease in 15 patients diagnosed with Ataxia-telangiectasia.
- Diagnosis criteria included neurological features and either oculo-cutaneous telangiectasia or elevated alpha-feto-protein.
Main Results:
- Recurrent sino-pulmonary infections were observed in 11 patients, typically starting within the first two years of life.
- Observed lung pathologies included bronchiectasis, airway obstruction/restriction, fibrosis, pneumothorax, and hemoptysis.
- Eleven patients presented with immunodeficiencies, contributing to lung disease.
Conclusions:
- Pulmonary manifestations often precede neurological complications in AT, with pulmonary status being a critical prognostic indicator.
- While immunodeficiency is a primary cause of lung disease in AT, it is not the sole factor.
- Increased awareness and proactive management of respiratory complications are crucial for improving outcomes in AT.
Related Concept Videos
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...